EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies

Simone Giuliano iD, Manjunath P Pai iD, Jacopo Angelini iD, Sarah Flammini, Luca Martini iD, Massimo Baraldo, Carlo Tascini iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2025

DOI: 10.1002/phar.70045 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2025. Verfasst von Simone Giuliano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Clinic, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. Hauptthemen laut MEDLINE: Daptomycin, Anti-Bacterial Agents, Drug Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Daptomycin is a once‐daily lipopeptide antibiotic with a narrow therapeutic window. As higher doses (8–12 mg/kg) are increasingly used to treat resistant gram‐positive infections, achieving therapeutic exposure while minimizing toxicity has become critical. Understanding daptomycin therapeutic drug monitoring (TDM) and what sampling strategy may be most precise and feasible are key to guiding appropriate dosing. The primary objective of this study was to ascertain the precision and bias of a mid‐point sample area under the curve over 24‐h (AUC 24 ) determination compared to a peak and trough sample AUC 24 determination using both simple calculation‐based methods and a Bayesian model versus no TDM.

Methods

Adult patients receiving daptomycin with at least three steady‐state concentrations (peak, mid‐point, trough) were included in this analysis. A previously published one‐compartment population pharmacokinetic model was applied using Bayesian estimation (Monolix Suite 2024R1). AUC 24 values were estimated using all three concentrations (AUC ref ), and then re‐estimated using individual samples (peak, mid‐point, or trough) or paired samples (peak + trough). Performance of each strategy was evaluated using regression analysis with the coefficient of determination for precision ( R 2 ) and mean bias.

Results

The cohort included 210 patients (60% male) with a mean (range) age of 66 (18–91) years, body weight 78 (41–140) kg, and BMI 27 (14–51) kg/m 2 . A total of 880 daptomycin concentrations were analyzed in patients receiving a mean (range) daptomycin dose of 9 (5–17) mg/kg. The mean (range) AUC 24 was 869 (385–1692) mg·h/L; only 45.7% of patients achieved the target range of 666 to 939 mg·h/L. A single mid‐point sample had similar correlation to AUC 24 ( R 2 = 0.57) as trough‐only ( R 2 = 0.55), and greater precision than peak‐only ( R 2 = 0.44). Bayesian estimation with two samples (peak + trough) provided the highest accuracy ( R 2 = 0.87) and lowest bias.

Conclusions

A mid‐interval sampling strategy offers a practical alternative to traditional TDM for daptomycin, enabling more consistent AUC estimation when full sampling is not feasible. A two‐sample Bayesian approach remains the most accurate, supporting broader implementation of individualized daptomycin dosing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaptomycinAnti-Bacterial AgentsDrug MonitoringHumansMaleMiddle AgedFemaleBayes TheoremAgedArea Under CurveAdultDose-Response Relationship, DrugAged, 80 and over

Stichwörter der Autor:innen

antibioticdaptomycindrug monitoringpharmacokineticsprecision medicine

Substanzen

DaptomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Infectious Diseases Clinic, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
  • Clinical Pharmacology and Toxicology Institute, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Department of Medicine (DMED), University of Udine (UNIUD), Udine, Italy.

ORCID-Profile: Simone Giuliano, Manjunath P Pai, Jacopo Angelini, Luca Martini, Carlo Tascini

Zitieren

APA

Giuliano, S., Pai, M. P., Angelini, J., Flammini, S., Martini, L., Baraldo, M., & Tascini, C. (2025). Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.70045

Vancouver

Giuliano S, Pai MP, Angelini J, Flammini S, Martini L, Baraldo M, et al. Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2025. doi:10.1002/phar.70045

BibTeX
@article{Giuliano2025,
  author = {Giuliano, Simone and Pai, Manjunath P and Angelini, Jacopo and Flammini, Sarah and Martini, Luca and Baraldo, Massimo and Tascini, Carlo},
  title = {Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2025},
  doi = {10.1002/phar.70045}
}
Kostenlos starten →